In humans, a single infusion of clonal NY-ESO-1-specific CD4 T cells in a metastatic melanoma patient resulted in complete resolution of pulmonary and nodal disease 2 months after ACT, suggesting that CD4 T cells alone were sufficient to trigger tumour elimination (140). This evidence concerns the gene CD4 and metastatic melanoma.